Skip to main content

Sigilon Therapeutics, Inc.

SGTXDelisted Aug 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001821323

Sigilon Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 15, 2023; 16 institutions reported holding it in 13F filings for Q2 2023, worth $26.6M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Sigilon Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of SGTX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders52520
Shares19.6M19.5M−125.6K (−0.6%)
Value$438.5M$209.2M−$229.3M (−52.3%)

New holders (11)

Institutions that held Sigilon Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to SGTX in Q2 2021
InstitutionSharesValue% of portfolio
Monashee Investment Management LLC317,460$3.41M0.41%
Jacobs Levy Equity Management, Inc66,086$709.0K0.00%
Soundmark Wealth Management, LLC55,555$595.0K0.24%
Two Sigma Investments, LP32,782$352.0K0.00%
Walleye Capital LLC32,050$344.0K0.01%
Cubist Systematic Strategies, LLC19,391$208.0K0.00%
Jump Financial, LLC15,200$163.0K0.02%
D. E. Shaw & Co., Inc.14,444$155.0K0.00%
Trexquant Investment LP11,293$121.0K0.01%
Signaturefd, LLC68$1.00K0.00%
Parallel Advisors, LLC96$1.00K0.00%

Sold out (11)

Institutions that held Sigilon Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of SGTX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Avidity Partners Management LP850,968$19.0M
UBS Asset Management Americas Inc123,374$2.76M
Millennium Management LLC104,101$2.33M
Caas Capital Management LP35,000$782.0K
Zimmer Partners, LP15,000$335.0K
Laurion Capital Management LP10,000$224.0K
STRS Ohio1,900$42.0K
HM Payson & Co1,028$23.0K
Bank of Montreal261$5.00K
Valeo Financial Advisors, LLC113$3.00K
Sowell Financial Services LLC38$0